Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells - PubMed (original) (raw)

. 2006 Mar 31;281(13):8806-14.

doi: 10.1074/jbc.M507305200. Epub 2006 Jan 23.

Affiliations

• PMID: 16431925
• DOI: 10.1074/jbc.M507305200

Free article

Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells

Jean Lu et al. J Biol Chem. 2006.

Free article

Abstract

Although spleen tyrosine kinase (Syk) is known to be important in hematopoietic cell development, the roles of Syk in epithelial cells have not been well studied. Limited data suggest that Syk plays alternate roles in carcinogenesis under different circumstances. In breast cancer, Syk has been suggested to be a tumor suppressor. In contrast, Syk is essential for murine mammary tumor virus-mediated transformation. However, the roles of Syk in tumor migration are still largely unknown. Nasopharyngeal carcinoma, an unusually highly metastatic tumor, expresses Epstein-Barr virus LMP2A (latent membrane protein 2A) in most clinical specimens. Previously, we demonstrated LMP2A triggers epithelial cell migration. LMP2A contains an immunoreceptor tyrosine-based activation motif, which is important for Syk kinase activation in B cells. In this study, we explored whether Syk is important for LMP2A-mediated epithelial cell migration. We demonstrate that LMP2A expression can activate endogenous Syk activity. The activation requires the tyrosine residues in LMP2A ITAM but not YEEA motif, which is important for Syk activation by Lyn in B cells. LMP2A interacts with Syk as demonstrated by coimmunoprecipitation and confocal microscopy. Furthermore, LMP2A-induced cell migration is inhibited by a Syk inhibitor and short interfering RNA. Tyrosines 74 and 85 in the LMP2A immunoreceptor tyrosine-based activation motif are essential for both Syk activation and LMP2A-mediated cell migration, indicating the involvement of Syk in LMP2A-triggered cell migration. The LMP2A-Syk pathway may provide suitable drug targets for treatment of nasopharyngeal carcinoma.

PubMed Disclaimer

Similar articles

• Epstein-Barr virus latent membrane protein-2A induces ITAM/Syk- and Akt-dependent epithelial migration through αv-integrin membrane translocation.
  Fotheringham JA, Coalson NE, Raab-Traub N. Fotheringham JA, et al. J Virol. 2012 Oct;86(19):10308-20. doi: 10.1128/JVI.00853-12. Epub 2012 Jul 25. J Virol. 2012. PMID: 22837212 Free PMC article.
• Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency.
  Fruehling S, Swart R, Dolwick KM, Kremmer E, Longnecker R. Fruehling S, et al. J Virol. 1998 Oct;72(10):7796-806. doi: 10.1128/JVI.72.10.7796-7806.1998. J Virol. 1998. PMID: 9733815 Free PMC article.
• The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction.
  Fruehling S, Longnecker R. Fruehling S, et al. Virology. 1997 Sep 1;235(2):241-51. doi: 10.1006/viro.1997.8690. Virology. 1997. PMID: 9281504
• Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction.
  Miller CL, Lee JH, Kieff E, Burkhardt AL, Bolen JB, Longnecker R. Miller CL, et al. Infect Agents Dis. 1994 Apr-Jun;3(2-3):128-36. Infect Agents Dis. 1994. PMID: 7812651 Review.
• Latent Membrane Protein 2 (LMP2).
  Cen O, Longnecker R. Cen O, et al. Curr Top Microbiol Immunol. 2015;391:151-80. doi: 10.1007/978-3-319-22834-1_5. Curr Top Microbiol Immunol. 2015. PMID: 26428374 Review.

Cited by

• Epstein-barr virus latent membrane protein 2B (LMP2B) modulates LMP2A activity.
  Rovedo M, Longnecker R. Rovedo M, et al. J Virol. 2007 Jan;81(1):84-94. doi: 10.1128/JVI.01302-06. Epub 2006 Oct 11. J Virol. 2007. PMID: 17035319 Free PMC article.
• The SYK tyrosine kinase: a crucial player in diverse biological functions.
  Mócsai A, Ruland J, Tybulewicz VL. Mócsai A, et al. Nat Rev Immunol. 2010 Jun;10(6):387-402. doi: 10.1038/nri2765. Nat Rev Immunol. 2010. PMID: 20467426 Free PMC article. Review.
• Transcriptome changes induced by Epstein-Barr virus LMP1 and LMP2A in transgenic lymphocytes and lymphoma.
  Shair KH, Raab-Traub N. Shair KH, et al. mBio. 2012 Sep 18;3(5):e00288-12. doi: 10.1128/mBio.00288-12. Print 2012. mBio. 2012. PMID: 22991431 Free PMC article.
• NF-κB as a target for oncogenic viruses.
  Sun SC, Cesarman E. Sun SC, et al. Curr Top Microbiol Immunol. 2011;349:197-244. doi: 10.1007/82_2010_108. Curr Top Microbiol Immunol. 2011. PMID: 20845110 Free PMC article. Review.
• The role of Epstein-Barr virus in epithelial malignancies.
  Tsao SW, Tsang CM, To KF, Lo KW. Tsao SW, et al. J Pathol. 2015 Jan;235(2):323-33. doi: 10.1002/path.4448. J Pathol. 2015. PMID: 25251730 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Miscellaneous

  • NCI CPTAC Assay Portal